Vir Biotechnology Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 246.45, 105.79, 161.23, 163.16, 346.33 ], "ebit_estimate": [ -341.76, -414.75, -329.37, -297.32, -257.4 ], "ebitda_estimate": [ -302.32, -398.27, -353.94, -304, -194.68 ], "net_income_estimate": [ -325.28, -386.09, -324.93, -350.28, -238.03 ], "per_share_eps_estimate": [ -2.16, -2.43, -1.92, -1.42, -1.24 ], "eps_nri_estimate": [ -2.1, -2.33, -1.79, -1.73, -1.18 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 4.39, 4.01, 3.52, null, null ], "pretax_income_estimate": [ -309.97, -390.84, -330.41, -287.16, -237.16 ], "operating_cash_flow_per_share_estimate": [ -1.3, -0.08, null, null, null ], "roa_estimate": [ -48.3, -51.7, null, null, null ], "roe_estimate": [ -49.23, -45.91, -54.86, null, null ], "gross_margin_estimate": [ 100, 93.43, 84.37, 85.37, 90 ], "operating_cash_flow_estimate": [ -191.56, -11.79, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": 14.76, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 12.89, "future_eps_nri_estimate_growth": 14.76, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": 8.9, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 6.99, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": -13.26, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -4.88, "future_gross_margin_estimate_growth": -5.6, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 216.46, 0.26, 6.94, 54.42, 16.01, 0.01, 0.01, 50.01 ], "ebit_estimate": [ -33.06, -120.07, -118.9, -65.6, -91.59, -106.11, -104.68, -69.27 ], "ebitda_estimate": [ 8.43, -124.25, -117.57, -63.15, -90.5, -104.19, -102.82, -67.18 ], "net_income_estimate": [ -24.76, -112.21, -111.23, -51.91, -84.4, -98.92, -97.49, -62.08 ], "per_share_eps_estimate": [ 0.18, -0.73, -0.65, -0.42, -0.69, -0.59, -0.67, -0.39 ], "eps_nri_estimate": [ 0.33, -0.75, -0.65, -0.46, -0.61, -0.6, -0.65, -0.39 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ 5.49, null, null, null, null, null, null, null ], "pretax_income_estimate": [ 1.13, -108.05, -107.89, -80.36, -84.4, -98.92, -97.49, -62.08 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ 100, 100, 100, 100, 100, 100, 100, 75 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 14.76, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 12.89, "future_eps_nri_estimate_growth": 14.76, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": 8.9, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 6.99, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": -13.26, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -4.88, "future_gross_margin_estimate_growth": -5.6, "future_operating_cash_flow_per_share_estimate_growth": null }